A Critical Review on the Long-Term COVID-19 Impacts on Patients With Diabetes.

Ashique, S; Mishra, N; Garg, A; Garg, S; Farid, A; Rai, S; Gupta, G; Dua, K; Paudel, KR; Taghizadeh-Hesary, F

A Critical Review on the Long-Term COVID-19 Impacts on Patients With Diabetes.

Ashique, S Mishra, N Garg, A Garg, S Farid, A Rai, S Gupta, G Dua, K

Paudel, KR Taghizadeh-Hesary, F

Permalink

Publisher:: Elsevier BV
Publication Type:: Journal Article
Citation:: Am J Med, 2024, pp. S0002-9343(24)00133-5
Issue Date:: 2024-03-12

Closed Access

	Filename	Description	Size
	A Critical Review on the Long-Term COVID-19 Impacts on Patients With Diabetes.pdf	Accepted version	1.85 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Ashique, S
dc.contributor.author	Mishra, N
dc.contributor.author	Garg, A
dc.contributor.author	Garg, S
dc.contributor.author	Farid, A
dc.contributor.author	Rai, S
dc.contributor.author	Gupta, G
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159
dc.contributor.author	Paudel, KR
dc.contributor.author	Taghizadeh-Hesary, F
dc.date.accessioned	2024-05-15T01:12:12Z
dc.date.available	2024-02-23
dc.date.available	2024-05-15T01:12:12Z
dc.date.issued	2024-03-12
dc.identifier.citation	Am J Med, 2024, pp. S0002-9343(24)00133-5
dc.identifier.issn	0002-9343
dc.identifier.issn	1555-7162
dc.identifier.uri	http://hdl.handle.net/10453/178971
dc.description.abstract	BACKGROUND: The world is currently grappling with the potentially life-threatening coronavirus disease 2019 (COVID-19), marking it as the most severe health crisis in the modern era. COVID-19 has led to a pandemic, with the World Health Organization (WHO) predicting that individuals with diabetes are at a higher risk of contracting the virus compared to the general population. This review aims to provide a practical summary of the long-term impacts of COVID-19 on patients with diabetes. Specifically, it focuses on the effects of SARS-CoV-2 on different types of diabetic patients, the associated mortality rate, the underlying mechanisms, related complications, and the role of vitamin D and zinc in therapeutic and preventive approaches. METHODS: Relevant literature was identified through searches on PubMed, Web of Science, and Science Direct in English, up to April 2023. RESULTS: COVID-19 can lead to distressing symptoms and pose a significant challenge for individuals living with diabetes. Older individuals and those with pre-existing conditions such as diabetes, coronary illness, and asthma are more susceptible to COVID-19 infection. Managing COVID-19 in individuals with diabetes presents challenges, as it not only complicates the fight against the infection but also potentially prolongs the recovery time. Moreover, the virus may thrive in individuals with high blood glucose levels. Various therapeutic approaches, including antidiabetic drugs, are available to help prevent COVID-19 in diabetic patients. CONCLUSIONS: Diabetes increases the morbidity and mortality risk for patients with COVID-19. Efforts are globally underway to explore therapeutic interventions aimed at reducing the impact of diabetes on COVID-19.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	Elsevier BV
dc.relation.ispartof	Am J Med
dc.relation.isbasedon	10.1016/j.amjmed.2024.02.029
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	11 Medical and Health Sciences
dc.subject.classification	General & Internal Medicine
dc.subject.classification	32 Biomedical and clinical sciences
dc.subject.classification	42 Health sciences
dc.title	A Critical Review on the Long-Term COVID-19 Impacts on Patients With Diabetes.
dc.type	Journal Article
utslib.location.activity	United States
utslib.for	11 Medical and Health Sciences
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Health
pubs.organisational-group	University of Technology Sydney/Faculty of Science
pubs.organisational-group	University of Technology Sydney/Strength - CFI - Centre for Inflammation
utslib.copyright.status	closed_access	*
dc.date.updated	2024-05-15T01:12:10Z
pubs.publication-status	Published online

Abstract:

BACKGROUND: The world is currently grappling with the potentially life-threatening coronavirus disease 2019 (COVID-19), marking it as the most severe health crisis in the modern era. COVID-19 has led to a pandemic, with the World Health Organization (WHO) predicting that individuals with diabetes are at a higher risk of contracting the virus compared to the general population. This review aims to provide a practical summary of the long-term impacts of COVID-19 on patients with diabetes. Specifically, it focuses on the effects of SARS-CoV-2 on different types of diabetic patients, the associated mortality rate, the underlying mechanisms, related complications, and the role of vitamin D and zinc in therapeutic and preventive approaches. METHODS: Relevant literature was identified through searches on PubMed, Web of Science, and Science Direct in English, up to April 2023. RESULTS: COVID-19 can lead to distressing symptoms and pose a significant challenge for individuals living with diabetes. Older individuals and those with pre-existing conditions such as diabetes, coronary illness, and asthma are more susceptible to COVID-19 infection. Managing COVID-19 in individuals with diabetes presents challenges, as it not only complicates the fight against the infection but also potentially prolongs the recovery time. Moreover, the virus may thrive in individuals with high blood glucose levels. Various therapeutic approaches, including antidiabetic drugs, are available to help prevent COVID-19 in diabetic patients. CONCLUSIONS: Diabetes increases the morbidity and mortality risk for patients with COVID-19. Efforts are globally underway to explore therapeutic interventions aimed at reducing the impact of diabetes on COVID-19.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/178971